Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from EPS Creative Health Technology Group Limited ( (HK:3860) ).
EPS Creative Health Technology Group Limited reported its interim financial results for the six months ended September 30, 2025, showing a revenue of approximately HK$223.9 million and a loss after taxation of HK$2.6 million. The company experienced a decline in revenue and profit compared to the same period in 2024, with no interim dividend recommended. This financial performance may impact the company’s market positioning and stakeholder confidence.
The most recent analyst rating on (HK:3860) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on EPS Creative Health Technology Group Limited stock, see the HK:3860 Stock Forecast page.
More about EPS Creative Health Technology Group Limited
EPS Creative Health Technology Group Limited operates in the health technology industry, focusing on innovative health solutions and services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 143,592
Technical Sentiment Signal: Buy
Current Market Cap: HK$339.4M
See more insights into 3860 stock on TipRanks’ Stock Analysis page.